Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

INGRID A MAYER

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1871677971
CMS profile
85141
Location
NASHVILLE, TN

General Payments · PY2018–2021

$129,861.54

  • Reported across 96 records
  • CMS publication 2026-01-23

Latest program year · PY2021

$26,397.42

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2021 · sorted by reported total

By paying entity

PY2021 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $10,388.00 2
AstraZeneca UK Limited $6,507.50 3
Merck Sharp & Dohme Corporation $3,500.00 1
Eli Lilly and Company $2,100.00 2
MACROGENICS, INC. $1,500.00 1
Blueprint Medicines Corporation $1,400.00 1
Genentech USA, Inc. $990.00 1
Gilead Sciences, Inc. $11.92 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $35,668.12 33
PY2019 $43,107.25 42
PY2020 $24,688.75 9
PY2021 $26,397.42 12

Payment records · PY2021 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2021 201820192020 Record-level detail is published for PY2021; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca UK Limited $2,055.00 05/17/2021 Consulting Fee Undisputed 01/23/2026 829603457 CMS
AstraZeneca UK Limited $2,055.00 07/21/2021 Consulting Fee Undisputed 01/23/2026 829558455 CMS
AstraZeneca UK Limited $2,397.50 10/11/2021 Consulting Fee Undisputed 01/23/2026 829934917 CMS
Blueprint Medicines Corporation $1,400.00 01/15/2021 Honoraria Undisputed 01/23/2026 848932341 CMS
Eli Lilly and Company $700.00 02/11/2021 Consulting Fee Undisputed 01/23/2026 818551767 CMS
Eli Lilly and Company $1,400.00 04/15/2021 Consulting Fee Undisputed 01/23/2026 818551275 CMS
Genentech USA, Inc. $990.00 09/01/2021 Consulting Fee Undisputed 01/23/2026 835919473 CMS
GENZYME CORPORATION $4,500.00 01/04/2021 Consulting Fee Undisputed 01/23/2026 843768073 CMS
GENZYME CORPORATION $5,888.00 07/14/2021 Consulting Fee Undisputed 01/23/2026 843768077 CMS
Gilead Sciences, Inc. $11.92 06/01/2021 Education Undisputed 01/23/2026 845876313 CMS
MACROGENICS, INC. $1,500.00 03/03/2021 Honoraria Undisputed 01/23/2026 833897703 CMS
Merck Sharp & Dohme Corporation $3,500.00 08/25/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 848309033 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.